Cargando…

Implications of Doppler Echocardiography-guided Heart Rate Modulation Using Ivabradine

OBJECTIVE: Heart rate modulation therapy using ivabradine reduces both morbidity and mortality in patients with systolic heart failure. However, the target heart rate for this patient population remains to be elucidated. METHODS: In this prospective observational study, we included patients with hea...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hori, Masakazu, Imamura, Teruhiko, Narang, Nikhil, Kinugawa, Koichiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Japanese Society of Internal Medicine 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8758464/ https://www.ncbi.nlm.nih.gov/pubmed/34148961 http://dx.doi.org/10.2169/internalmedicine.7343-21

Ejemplares similares

Doppler Echocardiography-Guided Heart Rate Modulation Therapy Using Ivabradine in a Patient with Systolic Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

Prognostic Implication of Small Dense LDL-Cholesterol Levels following Acute Coronary Syndrome
por: Imamura, Teruhiko, et al.
Publicado: (2023)

Pressure Ramp Testing for Optimization of End-Expiratory Pressure Settings in Adaptive Servo-Ventilation Therapy
por: Hori, Masakazu, et al.
Publicado: (2021)

Lung Fluid Volume during Cardiopulmonary Exercise Testing
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Implication of Mineralocorticoid Receptor Antagonist Esaxerenone in Patients With Heart Failure With Preserved Ejection Fraction
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Clinical Implications of Sodium Zirconium Cyclosilicate Therapy in Patients with Systolic Heart Failure and Hyperkalemia
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Change in Lung Fluid Volume during Exercise in Patients with Exercise-Induced Mitral Regurgitation
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Comment on: Efficacy of early initiation of ivabradine treatment in patients with acute heart failure: Rationale and design of SHIFT‐AHF trial
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Adaptive Servo-Ventilation as a Novel Therapeutic Strategy for Chronic Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Impact of Sodium Zirconium Cyclosilicate Therapy Cessation in Patients with Systolic Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Management of hyperkalemia in chronic heart failure using sodium zirconium cyclosilicate
por: Oshima, Akira, et al.
Publicado: (2021)

Optimal Therapeutic Strategy Using Sacubitril/Valsartan in a Patient with Systolic Heart Failure and Chronic Kidney Disease - An Initial Case Report in Japan
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Chronotype of Lung Fluid Levels in Patients with Chronic Heart Failure
por: Ueno, Yohei, et al.
Publicado: (2022)

Impact of Hypoxia-Inducible Factor Prolyl Hydroxylase Inhibitor on Heart Failure with Preserved Ejection Fraction
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Association between Pemafibrate Therapy and Triglyceride to HDL-Cholesterol Ratio
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Risk Factors for Rapid Recurrence of Hyperkalemia following Cessation of Sodium Zirconium Cyclosilicate
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Clinical Implication of Ivabradine Administration Before Non-Cardiac Surgery
por: Imamura, Teruhiko
Publicado: (2021)

Renoprotective Effect of the Mineralocorticoid Receptor Antagonist Esaxerenone
por: Oshima, Akira, et al.
Publicado: (2021)

Impact of Sodium Zirconium Cyclosilicate Therapy on Nutrition Status in Patients with Hyperkalemia
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Patient Selection for Pemafibrate Therapy to Prevent Adverse Cardiovascular Events
por: Izumida, Toshihide, et al.
Publicado: (2022)

Implication of Ivabradine in Patients with Acute Heart Failure and Sinus Tachycardia Following Allogenic Hematopoietic Cell Transplantation
por: Henmi, Heisuke, et al.
Publicado: (2022)

Prognostic Implications of a Modified Seattle Heart Failure Model Score Following Transcatheter Aortic Valve Replacement
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Combination Therapy Using Sodium Zirconium Cyclosilicate and a Mineralocorticoid Receptor Antagonist in Patients with Heart Failure and Hyperkalemia
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Optimal Heart Rate and Prognosis in Patients with Cardiac Amyloidosis
por: Izumida, Toshihide, et al.
Publicado: (2021)

Optimization of pressure settings during adaptive servo-ventilation support using real-time heart rate variability assessment: initial case report
por: Imamura, Teruhiko, et al.
Publicado: (2017)

Combination therapy using tafamidis and neurohormonal blockers for cardiac amyloidosis and a reduced ejection fraction: a case report
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Triglyceride and Small Dense LDL-Cholesterol in Patients with Acute Coronary Syndrome
por: Hori, Masakazu, et al.
Publicado: (2021)

Novel Ramp Test to Optimize Pressure Setting of Adaptive Servo-Ventilation Using Non-Invasive Lung Fluid Level Quantification
por: Hori, Masakazu, et al.
Publicado: (2022)

A Case of T/NK-Cell Post-Transplantation Lymphoproliferative Disease 7 Years after Heart Transplantation
por: Nakamura, Makiko, et al.
Publicado: (2022)

Novel rate control strategy with landiolol in patients with cardiac dysfunction and atrial fibrillation
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Practical Therapeutic Management of Percutaneous Atrial Septal Defect Closure
por: Tanaka, Shuhei, et al.
Publicado: (2021)

Using Tissue Doppler and Speckle Tracking Echocardiography to Assess if Ivabradine Improves Right Ventricular Function
por: Gul, Murat, et al.
Publicado: (2021)

Urine Aquaporin-2: A Promising Marker of Response to the Arginine Vasopressin Type-2 Antagonist, Tolvaptan in Patients with Congestive Heart Failure
por: Imamura, Teruhiko, et al.
Publicado: (2016)

Implications of Elevated Fibrosis-4 Index in Patients Receiving Trans-Catheter Aortic Valve Replacement
por: Imamura, Teruhiko, et al.
Publicado: (2021)

Initial Experience With Tafamidis Treatment for Transthyretin Amyloid Cardiomyopathy
por: Nakamura, Makiko, et al.
Publicado: (2020)

Advances in Hemodynamic Monitoring in Heart Failure Patients
por: Imamura, Teruhiko, et al.
Publicado: (2020)

Association between Lung Fluid Levels Estimated by Remote Dielectric Sensing Values and Invasive Hemodynamic Measurements
por: Imamura, Teruhiko, et al.
Publicado: (2022)

Initial Experience of Vericiguat Treatment in Patients with Heart Failure and Reduced Ejection Fraction
por: Nakamura, Makiko, et al.
Publicado: (2023)

Prognostic Impact of Polypharmacy following Trans-Catheter Aortic Valve Replacement
por: Imamura, Teruhiko, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_sd9dg8kc1uip4s7f6avcm9qjed